Target intelligence / Profile preview

Herpes simplex virus protein UL12.5 (UL12.5)

Target
UL12.5
Molecular classification
Enzyme, Nuclease, Viral protein
01

Overview

Herpes simplex virus protein UL12.5 (UL12.5) is a viral protein that serves as a critical molecular trigger for the reactivation of herpes simplex virus (HSV-1 and HSV-2) from latency in the nervous system. Identified as a truncated isoform of the UL12 alkaline nuclease, UL12.5 does not primarily function in DNA replication but instead highjacks host neuronal sensing pathways to initiate the transition from dormancy to lytic infection. By detecting cellular stress signals—such as those from fever, UV exposure, or concurrent infections—UL12.5 activates the viral replication machinery, leading to recurrent outbreaks of cold sores or genital herpes. As the first viral protein identified to be essential for the reactivation process, it has emerged as a promising therapeutic target for preventing viral flare-ups. Current drug development efforts are focused on identifying small-molecule inhibitors that can block UL12.5 function, potentially maintaining the virus in a permanent latent state and reducing the risk of transmission and associated complications like encephalitis or Alzheimer's disease.

Other names
UL12.5HSV reactivation triggerViral alkaline nuclease isoform UL12.5
02

Mechanism of action

Inhibition of UL12.5 function prevents the virus from sensing cellular stress signals and initiating the transition from latency to lytic replication.

03

Biological functions

Viral reactivationImmune evasionSignal transductionHost cell hijacking
04

Disease associations

InfectionNeurodegenerative diseaseInflammation
05

Safety considerations

Specificity for viral vs. host nucleasesBlood-brain barrier penetration for drug deliveryPotential for off-target effects on host sensing pathways
06

Biomarkers

UL12.5 mRNA levelsViral DNA load in neuronsNKT cell activity

Beyond the preview

Go deeper on Herpes simplex virus protein UL12.5 (UL12.5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herpes simplex virus protein UL12.5 (UL12.5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call